Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 46,774 shares at $85.28 ($4.1M) on 2026-07-06, disclosed to the SEC on 2026-07-08.
Scheduled sale ($4.1M) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.28 | 426 | $36K | 0.9% |
| 2 | $85.35 | 8,786 | $750K | 18.3% |
| 3 | $86.32 | 10,090 | $871K | 21.3% |
| 4 | $86.34 | 385 | $33K | 0.8% |
| 5 | $87.03 | 2,474 | $215K | 5.3% |
| 6 | $87.17 | 3,956 |
| $345K |
| 8.4% |
| 7 | $89.03 | 11,369 | $1.0M | 24.7% |
| 8 | $89.44 | 9,288 | $831K | 20.3% |
| Total | $87.52 avg | 46,774 | $4.1M | 100% |
| Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |
| PTCT | SELL | 2026-04-03 | $3.6M | — | Filing → |